about
Virus infections and cytokines: can we manage the interactions?Persistence of dormant tumor cells in the bone marrow of tumor cell-vaccinated mice correlates with long-term immunological protectionTumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transferImmunotherapy of malignancy by in vivo gene transfer into tumors.Transformation-dependent expression of interleukin genes delivered by a recombinant parvovirus.Induction of cellular immunity in chimpanzees to human tumor-associated antigen mucin by vaccination with MUC-1 cDNA-transfected Epstein-Barr virus-immortalized autologous B cells.Cloning and sequencing of defective particles derived from the autonomous parvovirus minute virus of mice for the construction of vectors with minimal cis-acting sequences.Use of an autonomous parvovirus vector for selective transfer of a foreign gene into transformed human cells of different tissue origins and its expression therein.Retroviral vectors displaying functional antibody fragments.In vivo anti-tumour activity of recombinant MVM parvoviral vectors carrying the human interleukin-2 cDNA.Delivery of anticancer drugs via isolated hepatic perfusion: a promising strategy in the treatment of irresectable liver metastases?Expression of interleukin 10 in human melanoma.A novel MVMp-based vector system specifically designed to reduce the risk of replication-competent virus generation by homologous recombination.Interferon-gamma-producing tumor induces host tumor-specific T cell responses.
P2860
Q33212318-F98D41CF-124F-4DB3-BF3C-EB4379B288C2Q35636865-17490E11-F79D-49E6-B9D5-C4D3181F61BFQ36230110-F685851F-F3B6-4AB7-9032-2560774B5AFEQ36309790-476B3248-1F28-4D00-A359-3A65424619B1Q36697316-518D8A12-8BA7-41B4-902B-1CA8313426A4Q37724672-2A793522-5DB3-46CB-A5C1-DBD196C9B84CQ39601855-B07F690B-636F-4C6C-AA5E-0C3352454F25Q40039355-B489A2E4-9876-459C-8912-0CCBA4B9733FQ40405683-98042EEB-C315-4736-ACB6-F9A7EAF87F98Q40498288-D0954E5E-DFB2-46D3-ABEC-D2FFE43234EDQ41741368-A50800F0-A59C-45E1-B1A7-09E5F8E0FEFCQ42067641-6620C8AC-5014-4806-9736-1A1AADCE13B3Q45736738-93015030-CB98-4233-B94A-D062C2489E14Q55423438-BAE969A6-DDCB-497F-A33C-2D353A59762F
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Lymphokine gene therapy for cancer.
@en
Lymphokine gene therapy for cancer.
@nl
type
label
Lymphokine gene therapy for cancer.
@en
Lymphokine gene therapy for cancer.
@nl
prefLabel
Lymphokine gene therapy for cancer.
@en
Lymphokine gene therapy for cancer.
@nl
P1433
P1476
Lymphokine gene therapy for cancer.
@en
P2093
Russell SJ
P304
P356
10.1016/0167-5699(90)90081-J
P577
1990-06-01T00:00:00Z